Review
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2673-2685
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2673
Table 1 Overview of the conventional therapies for inflammatory bowel disease
Therapeutic agentActive compoundMode of actionRef.
Aminosalicylates (ASA)5-ASADecreases MPO activity, inhibits β-catenin activation[23]
Inhibits the generation and activity of IL-1β, IL-4, IL-5, IL-8, granulocyte-macrophage colony stimulating factor, and TNF-α
CorticosteroidsCorticosteroids[24]
ImmunosuppressantsAzathioprineClinical remission[25]
6-mercaptopurineMucosal healing
Cyclosporine A
Tacrolimus
Methotrexaten
AntibioticsMetronidazoleDecrease disease activity index[26]
CiprofloxacinMaintain remission
Biological therapyInfliximabNeutralizes TNF-α[27]
AdalimumabReduces inflammation
Certolizumab